NanoView Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- NanoView Biosciences's estimated annual revenue is currently $1.3M per year.
- NanoView Biosciences's estimated revenue per employee is $84,000
Employee Data
- NanoView Biosciences has 15 Employees.
- NanoView Biosciences grew their employee count by -67% last year.
NanoView Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | US Service Manager | Reveal Email/Phone |
NanoView Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.6M | 32 | -22% | N/A | N/A |
#2 | $3.4M | 30 | N/A | N/A | N/A |
#3 | $6.9M | 55 | 49% | $32M | N/A |
#4 | $0.8M | 10 | -23% | N/A | N/A |
#5 | $0.6M | 9 | -18% | N/A | N/A |
#6 | $4M | 36 | N/A | N/A | N/A |
#7 | $1.9M | 27 | 50% | $81.7M | N/A |
#8 | $18.8M | 134 | -28% | N/A | N/A |
#9 | $5.2M | 49 | 0% | $1.5M | N/A |
#10 | $0.3M | 4 | N/A | N/A | N/A |
What Is NanoView Biosciences?
NanoView Biosciences, is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biology of cellular communication and provide improved insight for how diseases are diagnosed, treated and monitored.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$1.3M
Revenue (est)
-67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NanoView Biosciences News
2022-04-20 - Global Nucleic Acid Labeling Market 2022 Data Analysis and ...
... Vector Laboratories, Promega Corporation, Agilent Technologies, Thermo Fisher Scientific, Inc, NanoView Biosciences Inc.
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | -12% | N/A |
#2 | $1.3M | 15 | -17% | N/A |
#3 | $1M | 15 | 0% | $50M |
#4 | $1.8M | 15 | N/A | N/A |
#5 | $0.9M | 15 | 0% | $13.3M |